All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Outcomes and Health Services Research | NCIT_C15829 | |
| Palliative Care, Other Than Pain and Hospice | NCIT_C15830 | [Supportive care that is not hospice or pain relief] |
| Pathobiology of Wasting and Growth Retardation | NCIT_C15831 | [Elucidate the pathogenic mechanisms of HIV-related opportunistic infections. Enhance a bidirectional flow between basic and clinical observations and intervention programs on HIV-related complications and foster interdisciplinary collaborations.] |
| Patient Oriented Research | NCIT_C15832 | [Studies of living individuals or groups of subjects (such as families, communities, or populations defined geographically or demographically), or material of human origin (such as tissues, specimens, and cognitive phenomena, etc.), for understanding of their physiologic and pathophysiologic characteristics, mechanisms of human diseases and development of approaches to diseases treatment and prevention. Includes the laboratory-based development of new forms of technology, studies of health-related professions, institutions, and systems, excludes disease-oriented studies of material, obtained from patients who were unknown to investigators.] |
| Human Subject Research | NCIT_C41385 | [A study that has gone beyond the laboratory research and the testing that can be done with experimental animals, and needs to involve humans if it is to be continued at all. Under current law, usually the testing of a new pharmaceutical product or medical device on humans is mandatory. The concept also refers to population-based research in which an investigator directly interacts with individuals.] |
| Pediatric Clinics and Services | NCIT_C15833 | |
| Pharmaceutical Resources | NCIT_C15834 | [A collection of pharmaceutical substances available for research use] |
| Phase I and II Vaccine Trials | NCIT_C15835 | [Select candidate vaccines or concepts suitable for Phase I and Phase II trials and conduct these trials.] |
| Vaccine Clinical Trial | NCIT_C15864 | |
| Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | NCIT_C15836 | [The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, or PLCO Trial, is a large-scale study to determine if certain tests will reduce the number of deaths from these cancers. Sponsored by the National Cancer Institute (NCI), the study will involve 148,000 men and women ages 55 through 74 at medical facilities in 9 geographic areas across the United States. (Cancer Facts Screening: Questions and Answers About the PLCO Cancer Screening Trial)] |
| Population Intervention | NCIT_C15837 | |
| Prevent Transmission of HIV/Safety Blood Supply | NCIT_C15838 | [Develop and assess multiple and concurrent ethical intervention strategies to reduce or prevent HIV transmission in both domestic and international settings.] |
| Prevention and Treatment Evaluation | NCIT_C15839 | |
| Therapy Evaluation | NCIT_C15857 | [Determining the efficacy of a particular therapy or treatment] |
| Hemoglobin C Crystals Measurement | NCIT_C112288 | [The determination of the amount of hemoglobin c crystals present in a sample.] |
| Other Than | NCIT_C151896 | [Distinct from those already mentioned, listed, or considered.] |
| Hendra Virus | NCIT_C112289 | [A species of enveloped and pleomorphic viruses in the Paramyxoviridae family and Henipavirus genus. The genome is composed of non-segmented, negative-sense, single-stranded RNA. Hendra viruses are found naturally in Pteropid fruit bats, and are zoonotic pathogens in domestic animals (mainly in horses) and humans. Hendra viruses cause respiratory diseases, meningitis and fatal encephalitis in humans.] |
| Acute Myeloid Leukemia with Germline CEBPA Mutation | NCIT_C151898 | [Familial acute myeloid leukemia (AML) syndrome associated with biallelic CEBPA mutations. Patients typically present with AML as children or young adults. The familial form of AML with germline CEBPA mutation has morphological and immunophenotypic features similar to those of sporadic AML with CEBPA mutations. Overall, it has a favorable prognosis. (WHO 2017)] |
| Unplanned | NCIT_C151899 | [Not expected or scheduled.] |
| Flow Microscopy | NCIT_C112284 | [A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells (presence of foreign particles, cell counts, protein aggregates, morphology information).] |